High-Dose Cholecalciferol Booster Therapy is Associated with a Reduced Risk of Mortality in Patients with COVID-19: A Cross-Sectional Multi-Centre Observational Study

High-Dose Cholecalciferol Booster Therapy is Associated with a Reduced Risk of Mortality in Patients with COVID-19: A Cross-Sectional Multi-Centre Observational Study

The worldwide pandemic of 2019 novel coronavirus disease (COVID-19) has posed the most substantial and severe public health issue for several generations, and therapeutic options have not yet been optimised. Vitamin D (in its “parent” form, cholecalciferol) has been proposed in the pharmacological m...

Full description

Bibliographic Details
Main Authors:	Stephanie F. Ling, Eleanor Broad, Rebecca Murphy, Joseph M. Pappachan, Satveer Pardesi-Newton, Marie-France Kong, Edward B. Jude
Format:	Article
Language:	English
Published:	MDPI AG 2020-12-01
Series:	Nutrients
Subjects:	SARS-CoV-2 COVID-19 vitamin D mortality cholecalciferol 25-hydroxyvitamin D
Online Access:	https://www.mdpi.com/2072-6643/12/12/3799

Similar Items

Efficacy of plain cholecalciferol versus ergocalciferol in raising serum vitamin D level in Thai female healthcare workers
by: Tanawat Amphansap, et al.
Published: (2022-12-01)

Efficacy of a Once-Monthly Pill Containing Ibandronate and Cholecalciferol on the Levels of 25-Hydroxyvitamin D and Bone Markers in Postmenopausal Women with Osteoporosis
by: In-Jin Cho, et al.
Published: (2015-09-01)

Vitamin D and activated vitamin D in tuberculosis in equatorial Malaysia: a prospective clinical study
by: Ralph, Anna P., et al.
Published: (2017)

Vitamin D insufficiency is high in Malaysia: A systematic review and meta-analysis of studies on vitamin D status in Malaysia
by: Shamin Mohd Saffian, et al.
Published: (2022-11-01)

The Efficacy and Safety of High-Dose Cholecalciferol Therapy in Hemodialysis Patients
by: Agnieszka Tarasewicz, et al.
Published: (2024-02-01)

Oral versus intramuscular cholecalciferol replacement in hemodialysis patients with vitamin D deficiency
by: Maha A. Behairy, et al.
Published: (2022-01-01)

Vitamin D Deficiency in Cushing’s Disease: Before and After Its Supplementation
by: Valentina Guarnotta, et al.
Published: (2022-02-01)

Persistent Increase in Serum 25-Hydroxyvitamin D Concentration in a Dog Following Cholecalciferol Intoxication
by: Charlotte Gerhard, et al.
Published: (2020-01-01)

Cholecalciferol or Calcifediol in the Management of Vitamin D Deficiency
by: Manuel Sosa Henríquez, et al.
Published: (2020-05-01)

Thoroughbred Racehorses in Hong Kong Require Vitamin D Supplementation to Mitigate the Risk of Low Vitamin D Status
by: Miranda C. M. Dosi, et al.
Published: (2023-06-01)

Efficacy and safety of vitamin D3 B.O.N intramuscular injection in Korean adults with vitamin D deficiency
by: Han Seok Choi, et al.
Published: (2016-12-01)

Calcitriol versus Cholecalciferol on Biochemical Markers of Metabolic Bone Disease in Very Low Birth Weight Infants: A Randomized Clinical Trial
by: Mohammad bagher Hosseini, et al.
Published: (2022-01-01)

Vitamin D and activated vitamin D in tuberculosis in equatorial Malaysia: a prospective clinical study
by: Anna P. Ralph, et al.
Published: (2017-04-01)

Vitamin D Deficiency : This clandestine endemic disease is veiled no more
by: Moeness Moustafa Alshishtawy
Published: (2012-05-01)

Vitamin D Deficiency; This clandestine endemic disease is veiled no more
by: Moeness Moustafa Alshishtawy
Published: (2012-05-01)

Correlation between 25-hydroxyvitamin D/D3 Deficiency and COVID-19 Disease Severity in Adults from Northern Colorado
by: Bridget A. Baxter, et al.
Published: (2022-12-01)

Vitamin D levels in Swiss breast cancer survivors
by: Michael Baumann, et al.
Published: (2018-01-01)

Vitamin-D2 treatment-associated decrease in 25(OH)D3 level is a reciprocal phenomenon: a randomized controlled trial
by: Muhammad M. Hammami, et al.
Published: (2019-01-01)

Effects of body fat mass and therapeutic weight loss on vitamin D status in privately owned adult dogs
by: Tabitha J. Hookey, et al.
Published: (2018-01-01)

The Influence of Different Cholecalciferol Supplementation Regimes on 25(OH) Cholecalciferol, Calcium and Parathyroid Hormone after Bariatric Surgery
by: Hendrika J.M. Smelt, et al.
Published: (2019-06-01)

Guidelines for Preventing and Treating Vitamin D Deficiency: A 2023 Update in Poland
by: Paweł Płudowski, et al.
Published: (2023-01-01)

Vitamin D Metabolite Profile in Cholecalciferol- or Calcitriol-Supplemented Healthy and Mammary Gland Tumor-Bearing Mice
by: Artur Anisiewicz, et al.
Published: (2020-11-01)

Pharmacokinetics of Oral Cholecalciferol in Healthy Subjects with Vitamin D Deficiency: A Randomized Open-Label Study
by: Angelo Fassio, et al.
Published: (2020-05-01)

Evaluating the Evidence in Clinical Studies of Vitamin D in COVID-19
by: Tom D. Thacher
Published: (2022-01-01)

Assessment of Vitamin D Metabolism in Patients with Cushing’s Disease in Response to 150,000 IU Cholecalciferol Treatment
by: Alexandra Povaliaeva, et al.
Published: (2021-11-01)

Early changes in 25-hydroxyvitamin D levelsand bone markers after monthly risedronatewith cholecalciferol in Korean patients with osteoporosis
by: Chung HY, et al.
Published: (2013-05-01)

A Randomized, Open-Label Study to Assess Efficacy of Weekly Assumption of Cholecalciferol versus Calcifediol in Older Patients with Hypovitaminosis D
by: Chukwuma Okoye, et al.
Published: (2022-01-01)

Physiological significance of vitamin D produced in skin compared with oral vitamin D
by: David R. Fraser
Published: (2022-01-01)

Pitfalls with Vitamin D Research in Musculoskeletal Disorders and Recommendations on How to Avoid Them
by: Gary M. Kiebzak, et al.
Published: (2019-09-01)

Beyond mineral metabolism, the bright immunomodulatory effect of vitamin D in renal disease
by: Baradaran Azar
Published: (2012-04-01)

Evaluation of Vitamin D Metabolism in Patients with Type 1 Diabetes Mellitus in the Setting of Cholecalciferol Treatment
by: Alexandra Povaliaeva, et al.
Published: (2020-12-01)

Editorial: Vitamin D Binding Protein, Total and Free Vitamin D Levels in Different Physiological and Pathophysiological Conditions
by: Zhongjian Xie, et al.
Published: (2020-02-01)

Reduction in Hypercalcemia Following Readjustment of Target Serum 25-Hydroxy Vitamin D Concentration during Cholecalciferol Therapy in Vitamin D-Deficient Critically Ill Patients
by: Roland N. Dickerson, et al.
Published: (2022-04-01)

Prevalence and factors influencing sub-optimal serum levels of 25-hydroxyvitamin D among children with sickle cell anaemia in south-west Nigeria
by: Adegoke SA
Published: (2017-12-01)

Effects on Serum Inflammatory Cytokines of Cholecalciferol Supplementation in Healthy Subjects with Vitamin D Deficiency
by: Angelo Fassio, et al.
Published: (2022-11-01)

THE ECONOMIC RATIONALE FOR THE SUPPLEMENTATION OF CHOLECALCIFEROL IN THE TREATMENT OF HYPERTENSION
by: Yakubova L. V.
Published: (2020-12-01)

A randomized controlled trial of cholecalciferol supplementation in patients on maintenance hemodialysis
by: Beena Bansal, et al.
Published: (2014-01-01)

Body fat and cholecalciferol supplementation in elderly homebound individuals
by: M.H.S. Canto-Costa, et al.
Published: (2006-01-01)

Importance and role of vitamin D in pharmaceutical practise
by: Radosław Jerzy Balwierz, et al.
Published: (2022-04-01)

Cholecalciferol Inhibits Cell Growth and Induces Apoptosis in the CaSki Cell Line
by: Sachin Bhoora, et al.
Published: (2020-02-01)